MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

Abbott Laboratories

Abierto

SectorSanidad

128.5 -1.05

Resumen

Variación precio

24h

Actual

Mínimo

127.11

Máximo

130.1

Métricas clave

By Trading Economics

Ingresos

7.6B

9.2B

Ventas

339M

11B

P/B

Media del Sector

17.001

57.333

BPA

1.09

Rentabilidad por dividendo

1.8

Margen de beneficios

84.099

Empleados

114,000

EBITDA

82M

3B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+11.42% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.80%

2.63%

Fecha Próximo Dividendo

15 may 2025

Próxima Fecha de Ex Dividendo

14 jul 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

3B

225B

Apertura anterior

129.55

Cierre anterior

128.5

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

Abbott Laboratories Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

16 abr 2025, 16:21 UTC

Ganancias

Abbott Labs Bracing for Tariffs as Profits Rise -- Update

16 abr 2025, 12:14 UTC

Ganancias

Abbott Labs 1Q Profit Jumps on Gains in Nutrition, Medical Devices

22 ene 2025, 19:03 UTC

Ganancias

Correction to Abbott Labs 4Q Sales Just Miss Estimates Article

22 ene 2025, 18:20 UTC

Ganancias

Abbott Labs 4Q Sales Just Miss Estimates; Shares Rise on 2025 Outlook -- Update

22 ene 2025, 12:45 UTC

Ganancias

Abbott Labs 4Q Sales Underwhelm Amid Diminished Demand for Covid-19 Related Sales

16 abr 2025, 15:09 UTC

Charlas de Mercado

Abbott Says Tariffs Killed Chances of an Outlook Raise -- Market Talk

16 abr 2025, 14:17 UTC

Ganancias

Abbott Laboratories Stock Rises as First-Quarter Earnings Surpass Expectations -- Barrons.com

16 abr 2025, 11:34 UTC

Ganancias

Abbott Labs 1Q Gross Margin of 52.8 % of Sales; Adj Gross Margin of 57.1 % >ABT

16 abr 2025, 11:33 UTC

Ganancias

Abbott Labs Projects FY25 Adj Operating Margin to Be 23.5% to 24.0% of Sales >ABT

16 abr 2025, 11:32 UTC

Ganancias

Abbott Labs Backs FY25 Adj EPS $5.05-Adj EPS $5.25 >ABT

16 abr 2025, 11:32 UTC

Ganancias

Abbott Labs Sees 2Q Adj EPS $1.23-Adj EPS $1.27 >ABT

16 abr 2025, 11:31 UTC

Ganancias

Abbott Labs Projects FY25 Organic Sales Growth of 7.5% to 8.5% >ABT

16 abr 2025, 11:30 UTC

Ganancias

Abbott Reaffirms Full-Yr Guidance

16 abr 2025, 11:30 UTC

Ganancias

Abbott Labs 1Q Organic Sales Growth Up 6.9% >ABT

16 abr 2025, 11:30 UTC

Ganancias

Abbott Labs 1Q Sales $10.36B >ABT

16 abr 2025, 11:30 UTC

Ganancias

Abbott Labs 1Q Net $1.33B >ABT

16 abr 2025, 11:30 UTC

Ganancias

Abbott Labs 1Q EPS 76c >ABT

16 abr 2025, 11:30 UTC

Ganancias

Abbott Labs 1Q Adj EPS $1.09 >ABT

16 abr 2025, 09:57 UTC

Acciones populares

Stocks to Watch: Nvidia, AMD, Heineken, ASML -- WSJ

1 feb 2025, 18:14 UTC

Principales Noticias

Musk's X Adds Nestlé, Colgate, Shell, Other Brands to Ad-Boycott Suit -- WSJ

22 ene 2025, 16:40 UTC

Principales Noticias
Ganancias

Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings. -- Barrons.com

22 ene 2025, 15:20 UTC

Ganancias

Abbott Laboratories Posts 'Middling' Quarter, But Diabetes Devices Shine -- IBD

22 ene 2025, 15:08 UTC

Ganancias

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 ene 2025, 13:51 UTC

Ganancias

Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit -- IBD

22 ene 2025, 13:39 UTC

Principales Noticias
Ganancias

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 ene 2025, 12:02 UTC

Ganancias

Abbott Labs Sees 1Q Adj EPS $1.05-Adj EPS $1.09 >ABT

22 ene 2025, 12:01 UTC

Ganancias

Abbott Labs Sees 2025 Adj EPS $5.05-Adj EPS $5.25 >ABT

22 ene 2025, 12:01 UTC

Ganancias

Abbott Labs Sees 2025 Adjusted Operating Margin 23.5%-24% >ABT

22 ene 2025, 12:00 UTC

Ganancias

Abbott Labs Sees 2025 Organic Sales Growth 7.5%-8.5% >ABT

22 ene 2025, 12:00 UTC

Ganancias

Abbott Labs 4Q Net $9.23B >ABT

Comparación entre iguales

Cambio de precio

Abbott Laboratories previsión

Precio Objetivo

By TipRanks

11.42% repunte

Estimación a 12 Meses

Media 144.15 USD  11.42%

Máximo 159 USD

Mínimo 127 USD

De acuerdo con 21 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Abbott Laboratories Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

21 ratings

18

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

128.52 / 129.7Soporte y Resistencia

Corto Plazo

Weak Bullish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.